Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Total Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | -- | 302,446 | 521,016 | 545,785 | 566,732 |
| General And Administrative Expense | -- | 302,446 | 521,016 | 545,785 | 566,732 |
| Other Operating Expenses | -- | 988,560 | 940,513 | 696,381 | 732,868 |
| Operating Expense | -- | 1.3M | 1.5M | 1.2M | 1.3M |
| Operating Income | -- | -1.3M | -1.5M | -1.2M | -1.3M |
| EBIT | -- | -1.3M | -1.5M | -1.2M | -1.3M |
| Net Interest Income | -- | -- | -- | -- | 0.00 |
| Other Income Expense | -- | 102,718 | 71,420 | -94,158 | -48,300 |
| Other Non Operating Income Expenses | -- | 86,235 | 80,735 | 24,525 | 76,347 |
| Special Income Charges | -- | 50,000 | 0.00 | -20,000 | -15,000 |
| Gain On Sale Of Security | -- | 16,483 | -9,315 | -98,683 | -109,647 |
| Pretax Income | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Tax Effect Of Unusual Items | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Net Income From Continuing Operation Net Minority Interest | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Net Income Including Noncontrolling Interests | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Net Income Common Stockholders | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Net Income | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| EBITDA | -- | -1.3M | -1.5M | -1.2M | -1.3M |
| Normalized EBITDA | -- | -1.3M | -1.5M | -1.1M | -1.2M |
| Basic EPS | -0.02 | -0.04 | -0.05 | -0.05 | -- |
| Diluted EPS | -0.02 | -0.04 | -0.05 | -0.05 | -- |
| Basic Average Shares | 29.3M | 28.3M | 22.4M | 22.4M | -- |
| Diluted Average Shares | 29.3M | 28.3M | 22.4M | 22.4M | -- |
| Total Unusual Items | -- | 16,483 | -9,315 | -118,683 | -124,647 |
| Total Unusual Items Excluding Goodwill | -- | 16,483 | -9,315 | -118,683 | -124,647 |
| Tax Rate For Calcs | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -- | -1.2M | -1.4M | -1.2M | -1.2M |
| Diluted NI Availto Com Stockholders | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Gain On Sale Of Ppe | -- | 50,000 | 29,842 | -- | -- |
| Impairment Of Capital Assets | -- | -- | 0.00 | 20,000 | 15,000 |
| Net Income Continuous Operations | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Net Non Operating Interest Income Expense | -- | -- | -- | -- | 0.00 |
| Other Gand A | -- | 286,726 | 411,664 | 321,151 | 306,156 |
| Rent And Landing Fees | -- | 15,720 | 15,720 | 15,720 | 15,720 |
| Rent Expense Supplemental | -- | 15,720 | 15,720 | 15,720 | 15,720 |
| Salaries And Wages | -- | 0.00 | 93,632 | 208,914 | 244,856 |
| Total Expenses | -- | 1.3M | 1.5M | 1.2M | 1.3M |
| Total Operating Income As Reported | -- | -1.3M | -1.5M | -- | -- |
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | -- | 182,928 | 1.3M | 1.4M | 1.2M |
| Cash Cash Equivalents And Short Term Investments | -- | 197,134 | 1.3M | 1.5M | 1.4M |
| Cash Financial | -- | 182,928 | 1.3M | 1.4M | 1.2M |
| Other Short Term Investments | -- | 14,206 | 47,723 | 65,788 | 164,471 |
| Accounts Receivable | -- | 81,742 | 13,665 | 154,058 | 86,619 |
| Receivables | -- | 81,742 | 13,665 | 154,058 | 86,619 |
| Prepaid Assets | -- | 89,879 | 94,153 | 70,502 | 47,461 |
| Current Assets | -- | 368,755 | 1.4M | 1.7M | 1.5M |
| Net PPE | -- | 787,736 | 757,736 | 470,236 | 400,236 |
| Total Non Current Assets | -- | 787,736 | 757,736 | 470,236 | 400,236 |
| Total Assets | -- | 1.2M | 2.2M | 2.2M | 1.9M |
| Payables And Accrued Expenses | -- | 128,295 | 75,335 | 21,856 | 21,563 |
| Other Current Liabilities | -- | 45,238 | 63,473 | 50,475 | -- |
| Current Liabilities | -- | 173,533 | 138,808 | 72,331 | 21,563 |
| Total Non Current Liabilities Net Minority Interest | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | -- | 173,533 | 138,808 | 72,331 | 21,563 |
| Common Stock | -- | 27.3M | 27.2M | 25.9M | 24.5M |
| Capital Stock | -- | 27.3M | 27.2M | 25.9M | 24.5M |
| Retained Earnings | -- | -35.8M | -34.6M | -33.3M | -32.0M |
| Common Stock Equity | -- | 982,958 | 2.0M | 2.1M | 1.9M |
| Stockholders Equity | -- | 982,958 | 2.0M | 2.1M | 1.9M |
| Total Equity Gross Minority Interest | -- | 982,958 | 2.0M | 2.1M | 1.9M |
| Total Capitalization | -- | 982,958 | 2.0M | 2.1M | 1.9M |
| Net Tangible Assets | -- | 982,958 | 2.0M | 2.1M | 1.9M |
| Tangible Book Value | -- | 982,958 | 2.0M | 2.1M | 1.9M |
| Working Capital | -- | 195,222 | 1.3M | 1.6M | 1.5M |
| Invested Capital | -- | 982,958 | 2.0M | 2.1M | 1.9M |
| Share Issued | -- | 29.3M | 27.8M | 24.0M | 20.4M |
| Ordinary Shares Number | -- | 29.3M | 27.8M | 24.0M | 20.4M |
| Other Equity Interest | -- | 9.5M | 9.5M | 9.5M | 9.3M |
| Line Item | FY 2025Jun 30, 2025 | FY 2024Jun 30, 2024 | FY 2023Jun 30, 2023 | FY 2022Jun 30, 2022 | FY 2021Jun 30, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | -- | -1.3M | -1.2M | -1.1M | -1.2M |
| Cash Flow From Continuing Operating Activities | -- | -1.3M | -1.2M | -1.1M | -1.2M |
| Stock Based Compensation | -- | 0.00 | 93,632 | 208,914 | 244,856 |
| Change In Working Capital | -- | -10,843 | 170,221 | -90,187 | -110,634 |
| Change In Receivables | -- | -68,077 | 140,393 | -67,439 | -69,575 |
| Change In Payables And Accrued Expense | -- | 52,960 | 53,479 | 293.00 | -28,708 |
| Other Non Cash Items | -- | -136,235 | -80,735 | -24,525 | -76,347 |
| Capital Expenditure | -- | -25,000 | -25,000 | -50,000 | -125,000 |
| Purchase Of PPE | -- | -25,000 | -25,000 | -50,000 | -125,000 |
| Net PPE Purchase And Sale | -- | 25,000 | -16,250 | -50,000 | -125,000 |
| Investing Cash Flow | -- | 25,000 | -16,250 | -50,000 | -125,000 |
| Cash Flow From Continuing Investing Activities | -- | 25,000 | -16,250 | -50,000 | -125,000 |
| Issuance Of Capital Stock | -- | 205,002 | 684,200 | 1.4M | 1.1M |
| Net Common Stock Issuance | -- | 205,002 | 684,200 | 1.4M | 1.1M |
| Financing Cash Flow | -- | 194,684 | 1.1M | 1.4M | 1.6M |
| Cash Flow From Continuing Financing Activities | -- | 194,684 | 775,750 | 1.4M | 1.6M |
| Changes In Cash | -- | -1.1M | -138,176 | 206,973 | 312,577 |
| Beginning Cash Position | -- | 1.3M | 1.4M | 1.2M | 883,717 |
| End Cash Position | -- | 182,928 | 1.3M | 1.4M | 1.2M |
| Free Cash Flow | -- | -1.3M | -1.2M | -1.2M | -1.3M |
| Income Tax Paid Supplemental Data | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Impairment Charge | -- | -- | 0.00 | 20,000 | 15,000 |
| Change In Prepaid Assets | -- | 4,274 | -23,651 | -23,041 | -12,351 |
| Common Stock Issuance | -- | 205,002 | 684,200 | 1.4M | 1.1M |
| Gain Loss On Sale Of PPE | -- | -50,000 | -29,842 | 0.00 | -- |
| Net Income From Continuing Operations | -- | -1.2M | -1.4M | -1.3M | -1.3M |
| Net Other Financing Charges | -- | -10,318 | 230,550 | -65,413 | -66,692 |
| Operating Gains Losses | -- | -50,000 | -29,842 | -- | -- |
| Proceeds From Stock Option Exercised | -- | 0.00 | 161,000 | 40,138 | 550,844 |
| Sale Of PPE | -- | 50,000 | 8,750 | 0.00 | -- |
| Unrealized Gain Loss On Investment Securities | -- | 33,517 | 39,157 | 98,683 | 109,647 |